ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a life sciences and biopharmaceutical-focused blank-check company sponsored by ARYA Sciences LLC, an affiliate of healthcare-dedicated investment firm Perceptive Advisors. The company completed its initial public offering in 2022, targeting opportunities across the biotechnology and life sciences sectors. On July 15, 2024, ARYD filed a Form DEFM14A with the Securities and Exchange Commission, a definitive proxy statement confirming the company had entered a proposed business combination agreement and was soliciting stockholder approval to advance the transaction. Sign up on SpacDesk for full filing data, deal timelines, and real-time analytics on ARYD and the broader SPAC universe.